Therefore, we hypothesize that the plasma CAVIN-1 levels in patients with T2DM and DM-PAD will also show an increasing trend.
← all excerpts
CAVIN-2 positively correlates with diabetic PAD and promotes LDL transcytosis by inhibiting eNOS activation.
1
—
—